Sesquiterpene farnesol contributes to increased susceptibility to β-lactams in strains of Burkholderia pseudomallei

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2198-2200

  Brilhante, R S N ^a   Valente, L G A ^a   Rocha, M F G ^a,b   Bandeira, T J P G ^a   Cordeiro, R A ^a   Lima, R A C ^a   Leite, J J G ^a   Ribeiro, J F ^a   Pereira, J F ^a   Castelo Branco, D S C M ^a   Monteiro, A J ^a   Sidrim, J J C ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b STATE UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; FARNESOL; GENTAMICIN; IMIPENEM; OXACILLIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DISK DIFFUSION; DRUG INHIBITION; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STANDARD;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; BURKHOLDERIA PSEUDOMALLEI; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; FARNESOL; MICROBIAL SENSITIVITY TESTS;

EID: 84858680325     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05885-11     Document Type: Article

References (18)

1. Brehm-Stecher BF, Johnson EA. 2003. Sensitization of Staphylococcus aureus and Escherichia coli to antibiotics by the sesquiterpenoids nerolidol, farnesol, bisabolol, and apritone. Antimicrob. Agents Chemother. 47: 3357-3360. (Pubitemid 37229606)
2. Cheng AC, Currie BJ. 2005. Melioidosis: epidemiology, pathophysiology, and management. Clin. Microbiol. Rev. 18:383-416. (Pubitemid 40548298)
3. Clinical and Laboratory Standards Institute. 2009. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. CLSI document M07-A8. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Derengowski LS, et al. 2009. Antimicrobial effect of farnesol, a Candida albicans quorum sensing molecule, on Paracoccidioides brasiliensis growth and morphogenesis. Ann. Clin. Microbiol. Antimicrob. 8:13.
5. Grace MH. 2002. Chemical composition and biological activity of the volatiles of Anthemis melampodina and Pluchea dioscoridis. Phytother Res. 16:183-185. (Pubitemid 34297465)
6. Inoue Y, et al. 2004. The antibacterial effects of terpene alcohols on Staphylococcus aureus and their mode of action. FEMS Microbiol. Lett. 237:325-331. (Pubitemid 39091968)
7. Jabra-Rizk MA, Meiller TF, James CE, Shirtliff ME. 2006. Effect of farnesol on Staphylococcus aureus biofilm formation and antimicrobial susceptibility. Antimicrob. Agents Chemother. 50:1463-1469.
8. Jabra-Rizk MA, Shirtliff M, James C, Meiller T. 2006. Effect of farnesol on Candida dubliniensis biofilm formation and fluconazole resistance. FEMS Yeast Res. 6:1063-1073. (Pubitemid 44568863)
9. Koo H, Rosalen PL, Cury JA, Park YK, Bowen WH. 2002. Effects of compounds found in propolis on Streptococcus mutans growth and on glucosyltransferase activity. Antimicrob. Agents Chemother. 46:1302-1309. (Pubitemid 34415306)
10. Kuroda M, Nagasaki S, Ohta T. 2007. Sesquiterpene farnesol inhibits recycling of the C55 lipid carrier of the murein monomer precursor contributing to increased susceptibility to β-lactams in methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother. 59:425-432. (Pubitemid 47073447)
11. Langford ML, Kenneth SH, Nickerson W, Atkin AL. 2010. Activity and toxicity of farnesol towards Candida albicans are dependent on growth conditions. Antimicrob. Agents Chemother. 54:940-942.
12. Medeiros JR, Campos LB, Mendonça SC, Davin LB, Lewis NG. 2003. Composition and antimicrobial activity of the essential oils from invasive species of the Azores, Hedychium gardnerianum and Pittosporum undulatum. Phytochemistry 64:561-565. (Pubitemid 37168976)
13. Semighini CP, Hornby JM, Dumitru R, Nickerson KW, Harris SD. 2006. Farnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungi. Mol. Microbiol. 59:753-764.
14. Thamlikitkul V, Trakulsomboon S. 2009. In vitro activity of doripenem against Burkholderia pseudomallei. Antimicrob. Agents Chemother. 53: 3115-3117.
15. Thibault FM, Hernandez E, Vidal DR, Girardet M, Cavallo JD. 2004. Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J. Antimicrob. Chemother. 54:1134-1138. (Pubitemid 40136755)
16. Unnanuntana A, Bonsignore L, Shirtliff ME, Greenfield EM. 2009. The effects of farnesol on Staphylococcus aureus biofilms and osteoblasts. J. Bone Joint Surg. Am. 91:2683-2692.
17. White NJ. 2003. Melioidosis. Lancet 361:1715-1722. (Pubitemid 36577448)
18. Wuthiekanun V, et al. 2005. Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei. J. Antimicrob. Chemother. 55:1029-1031. (Pubitemid 40883194)